TIDMINHC
RNS Number : 1219N
Induction Healthcare Group PLC
28 September 2021
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Publication of Annual Financial Report & Notice of AGM
Induction (AIM: INHC), a leading virtual care platform driving
digital transformation of healthcare systems worldwide, announces
that the Annual Report and Accounts, Notice of Annual General
Meeting ("AGM") and associated Form of Proxy, available on the
Company's website, have been posted to those shareholders who have
opted out of electronic communications .
The documents are available here:
https://inductionhealthcare.com/investors/financial-reports-and-publications/
The Company's AGM will be held at 50 Liverpool Street, London
EC2M 7PY at 09.00 am on Thursday 4 November 2021.
In light of the recent easing by the UK Government of COVID-19
restrictions, the Company anticipates that it will be able to hold
the AGM in the normal way this year. If so, this will mean that
shareholders will be welcome to attend the AGM in person. However,
given the constantly evolving nature of the situation, should the
COVID-19 restrictions change such that the Company considers it is
no longer possible for shareholders to attend the meeting, the AGM
will be held as a closed meeting instead. In the event that the AGM
arrangements have to change, the Company will issue a further
communication via a regulatory information service and on the
Company website at https://inductionhealthcare.com/investors/ .
Shareholders are therefore strongly encouraged to complete and
return the Form of Proxy in accordance with the instructions set
out therein to the Company's registrars, Equiniti Limited, Aspect
House, Spencer Road, Lancing, West Sussex, BN99 6DA, as soon as
possible but in any event so as to arrive no later than 09.00 am on
Tuesday 2 November 2021. Given the potential restrictions on
attendance, members are strongly encouraged to appoint the 'Chair
of the Meeting' as their proxy rather than a named person who may
not be permitted to attend the meeting.
Alternatively, eligible shareholders who hold their shares in
the Company in uncertificated form in CREST may use the CREST Proxy
Voting Service, details in respect of which are contained in the
notes to the notice of the AGM. Electronic Proxy Appointment
('EPA') is also available for this meeting. To use this facility,
investors must visit www.sharevote.co.uk where details of the
procedure are shown. Details on how to lodge your vote
electronically are contained within the notes to the Notice of
AGM.
The results of voting on the resolutions will be announced via a
regulatory information service and posted on the Company's website
as soon as practicable possible after the AGM.
In order to give shareholders a chance to engage in a meaningful
dialogue with the Company's management, please email the Company
Secretary at Alison.t@inductionhealthcare.com with any questions on
the business of the AGM or the Report and Accounts in advance of
the meeting stating your name (as printed on your Form of Proxy).
The questions will be collated and a representative sample will be
selected and answered on the Company's website at
https://inductionhealthcare.com/ as soon as practicable after the
conclusion of the AGM.
-ENDS-
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
James Balmain, Chief Executive Officer
Dr Hugo Stephenson, Group Executive
Director
Singer Capital Markets (Nominated
Adviser and Broker) +44 (0) 20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd induction@walbrookpr.com
Paul McManus / Alice Woodings Mob: +44(0)7980 541 893 / +44 (0)7407
804 654
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) is a leading virtual care platform driving
digital transformation of healthcare systems worldwide. Induction
solutions enhance the investments hospitals have made and lay the
foundation for their future. Our products can enable information
sharing between busy doctors, alleviate operational burdens on
hospitals or put patients in better control of their care, all
while ensuring the highest standards of clinical safety and
information security. We unchain staff and patients from the
limitations of paper-based and desktop systems, creating
substantial time and cost efficiencies.
More than 225,000 hospital doctors across multiple territories,
including the UK, Ireland, Australia and South Africa, as well as a
rapidly growing number of more than 300,000 UK patients, choose
Induction solutions.
Induction Switch is the number one healthcare collaboration app
in the UK, used by the majority of hospital doctors within the NHS.
The app helps to increase productivity and enhance communication by
securely sharing phone numbers and bleeps, bookmarks, documents and
messages in a clinical setting.
Induction Guidance provides medical organisations, including
most hospital trusts within the NHS, with the ability to
collaboratively create, edit, and publish their own local medical
guidelines in a secure and locally administrated environment. This
increases knowledge of, and adherence to, guidance.
Induction Zesty is a market-leading digital platform for
patients visiting hospitals. The platform allows patients to book
and access their appointments, read their clinical letters, store a
copy of their clinical record and provide data to their care teams
remotely. It is not just a compelling patient experience, but also
delivers significant cost benefits to hospitals.
Induction Attend Anywhere is the UK market leader in secondary
care video consultations. It helps hospitals, health systems and
other customers offer video consultations to patients and service
users as a normal part of day-to-day clinical activity. Our vision
is for video consultations to improve lives and help address
social, access, equity and sustainability challenges by allowing
healthcare providers to determine how and when they see a patient
based on each individual case: in-person, via video or on the
telephone.
Induction HealthStream is a proprietary data integration
platform that reads and writes patient demographic, appointment and
clinical record data between a growing number of hospital EHR
systems and the Induction platforms. This connectivity between
stakeholders and legacy IT systems adds substantial value to
pre-existing health IT investment and allows large-scale adoption
of Induction app-based services.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOAFLFEEADIDFIL
(END) Dow Jones Newswires
September 28, 2021 02:00 ET (06:00 GMT)
Induction Healthcare (LSE:INHC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Induction Healthcare (LSE:INHC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
